© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
September 29, 2020
An analysis of data from the Women's Health Initiative is offering clinicians a look into the impact of menopause symptoms on cardiovascular health in older women.
September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
September 18, 2020
New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.
September 17, 2020
Data from the WHI indicates adverse pregnancy outcomes were associated with increased risk of ASCVD later in life.
September 11, 2020
An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.
September 06, 2020
Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.
September 05, 2020
An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.
September 04, 2020
Full results of DAPA-CKD further inform clinicians on dapagliflozin and use of SGLT2 inhibitors in those with and without diabetes.
September 03, 2020
An ESC Congress 2020 study details the predictive value of galectin-3 levels for predicting risk of cardiovascular events in patients with type 2 diabetes
September 02, 2020
A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.